Virtu Financial’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25K | Sell |
20,757
-4,865
| -19% | -$5.86K | ﹤0.01% | 1232 |
|
|
2025
Q1 | $36K | Buy |
25,622
+21,904
| +589% | +$30.8K | ﹤0.01% | 1048 |
|
|
2024
Q4 | $20K | Buy |
3,718
+2,177
| +141% | +$11.7K | ﹤0.01% | 1299 |
|
|
2024
Q3 | $11K | Buy |
1,541
+622
| +68% | +$4.44K | ﹤0.01% | 1192 |
|
|
2024
Q2 | $9K | Sell |
919
-1,337
| -59% | -$13.1K | ﹤0.01% | 1138 |
|
|
2024
Q1 | $34K | Buy |
+2,256
| New | +$34K | ﹤0.01% | 1082 |
|
|
2023
Q2 | – | Sell |
-712
| Closed | -$18K | – | 1655 |
|
|
2023
Q1 | $18K | Buy |
+712
| New | +$18K | ﹤0.01% | 1261 |
|
|
2022
Q3 | – | Sell |
-222
| Closed | -$36K | – | 1858 |
|
|
2022
Q2 | $36K | Sell |
222
-146
| -40% | -$23.7K | ﹤0.01% | 1205 |
|
|
2022
Q1 | $91K | Buy |
368
+180
| +96% | +$44.5K | 0.01% | 996 |
|
|
2021
Q4 | $131K | Buy |
188
+115
| +158% | +$80.1K | 0.01% | 1006 |
|
|
2021
Q3 | $113K | Buy |
73
+2
| +3% | +$3.1K | 0.01% | 1102 |
|
|
2021
Q2 | $126K | Sell |
71
-171
| -71% | -$303K | 0.01% | 1140 |
|
|
2021
Q1 | $556K | Buy |
242
+228
| +1,629% | +$524K | 0.04% | 468 |
|
|
2020
Q4 | $45K | Buy |
+14
| New | +$45K | ﹤0.01% | 1245 |
|
|
2020
Q3 | – | Sell |
-15
| Closed | -$70K | – | 1191 |
|
|
2020
Q2 | $70K | Buy |
+15
| New | +$70K | 0.01% | 952 |
|
|
2018
Q2 | – | Hold |
0
| – | -$23K | – | 2094 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1806 |
|